MeSH Browser

MeSH Supplementary: compound 21
Unique ID: C000711730
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C000711730
Entry Term(s): C-21; C-21 sodium; C21; C21 sodium; butyl (3-(4-((1H-imidazol-1-yl)methyl)phenyl)-5-isobutylthiophen-2-yl)sulfonylcarbamate; compound 21 sodium
Pharm Action: Anti-Inflammatory Agents
Registry Number: RC2V4W0EYC
Related Numbers: Y151F1Q61I
Heading Mapped to: *Imidazoles; *Sulfonamides; *Thiophenes
Frequency: 92
Date of Entry: 2020/12/14
Revision Date: 2021/05/11

Concept UI: M000741785
Registry Number: RC2V4W0EYC
Related Numbers: Y151F1Q61I
Terms: compound 21 Preferred Term
Term UI T001106201
Date05/11/2021
LexicalTag LAB
ThesaurusID NLM (2021); butyl (3-(4-((1H-imidazol-1-yl)methyl)phenyl)-5-isobutylthiophen-2-yl)sulfonylcarbamate
Term UI T001093229
Date12/14/2020
LexicalTag NON
ThesaurusID FDA SRS (2017); C-21
Term UI T001093226
Date12/14/2020
LexicalTag NON
ThesaurusID FDA SRS (2017); C21
Term UI T001093228
Date12/14/2020
LexicalTag NON
ThesaurusID FDA SRS (2017)

compound 21 MeSH Supplementary Concept Data 2023